Evidence Library
Filter by drug, type, year, and open access.
Showing 1–4 of 4 results
- CANMAT/ISBD guidance on valproate for bipolar disorder — Bipolar Disorders (2021)• Drug: valproate-divalproexDOI
- Bipolar disorder: assessment and management (NICE guideline CG185) — National Institute for Health and Care Excellence (2020)• Drug: valproate-divalproexOpen access
- AGNP Consensus Guidelines for TDM in Psychiatry — Pharmacopsychiatry (2018)• Drug: valproate-divalproexOpen access
- Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis — Journal of Affective Disorders (2010)• Drug: valproate-divalproexDOI